Given that western blotting is primarily utilized for HIV detection, rising HIV incidence is anticipated to propel the global western blotting market throughout the forecast period. For instance, 1.5 million persons acquired a new HIV infection in 2021, according to data published by UNAIDS, a Joint United Nations Programme involved in data gathering on HIV epidemiology, which was released in January 2022.
The global Western Blotting Market is estimated to be valued at US$ 759.5 million in 2023 and is expected to exhibit a CAGR of 6.8% during the forecast period (2023-2030).
Key Companies in the Western Blotting Industry:
1. Thermo Fisher Scientific, Inc
Thermo Fisher Scientific, Incwas founded in 1956 and it’s headquarter in Waltham, Massachusetts, United States, United States.The company operates in 50 countries. Thermo Fisher Scientific Inc. is one of the leading companies in research antibodies and reagent market
2. GE HealthCare
GE HealthCare was launch in 1892. And its headquarter - Chicago, Illinois, U.S.. It operate over 160 country.
3. F. Hoffmann-La Roche Ltd
F. Hoffmann-La Roche Ltd,was launch in 1896 and it’s headquarter located in Basel, Switzerland. It operate over 150 country. 2022 — F. Hoffmann-La Roche Ltd: Roche launches new diagnostic test for the better understanding of immune response to SARS-CoV-2.
